Skeptic Ginger
Nasty Woman
- Joined
- Feb 14, 2005
- Messages
- 96,955
Right, nothing to do with you repeating the rosy picture for which pretty much everyone else knows it is a lie.
As you say, the monitoring would pick up on symptomatic infection, not on asymptomatic infection - the most common sort. And the regular samples that were taken would be subject to the problem that probably nobody who care about their own, or their lab’s future would publish any positive findings.No. I am suggesting that as lab workers working in the wild with bats known to carry coronavirus, their health would be monitored and they would report any incidents such a bite from a bat or protective gear failure. The monitoring would pick up symptomatic infection. The monitoring might include regular samples that would be tested after the outbreak was known.
That is correct. The lab close to the market is the Wuhan CDC lab which also collected bat samples. Its relocation was an argument for a laboratory incident in the March 2021 WHO study (the other was just that lab accidents happen). The argument against this is that the CDC lab reported no issue with the move and "reported no storage nor laboratory activities on CoVs or other bat viruses preceding the outbreak".
Nothing to do with my posts on the source of SARS-CoV-2. What I have written is that the evidence isRight, nothing to do with you repeating the rosy picture for which pretty much everyone else knows it is a lie.
Nothing to do with my posts on the source of SARS-CoV-2. What I have written is that the evidence is
This is the scientific consensus on the SARS-CoV-2 origin.
- The most probable source of the virus is animals with bats as the leading candidate.
- The least likely source is a lab leak (I disagree with the WHO study's use of "extremely unlikely").
You expect them to have spelled that out in the report? Are you seriously that naive?Skeptic Ginger, give the pages of the "whole section on the fact China told the WHO team this was so but refused and still refuses to let them see any actual evidence" in the WHO study.
WHO-convened global study of origins of SARS-CoV-2: China Part
Note that your "this was so" is that the WIV had a staff health monitoring programme. Evidence would include staff stating they were in a health monitoring programme. What China did in July 2021 is refuse to allow a follow-up WHO study: China rejects WHO plan for study of COVID-19 origin
You expect them to have spelled that out in the report? Are you seriously that naive?
....
Did you miss the whole section on the fact China told the WHO team this was so but refused and still refuses to let them see any actual evidence?
No I didn't as a matter of fact. I meant section in this thread. And BTW, I don't see "section of the report" in my sentence at all.So you didn't mean "section of the REPORT" when you typed this?
If not, section of what?
That is what you wrote in response to my post about the WHO study. The quotes are from your post. Actually answer the question instead of linking to an irrelevant news report.You expect them to have spelled that out in the report? Are you seriously that naive?...
First it was the BSL-4 lab so we needed to investigate the WiV because they study Corona viruses there.
The BSL-4 lab was too far away from the epicenter so it was the WiV work in BSL-2 and BSL-3 labs (which exist in nearly every large city, so much for it being "to much of a coincidence")
But the WiV is still in the wrong place but there is another lab that is closer.
Expect this lab isn't used by the WiV it's used by the CCDC, so now after a year of accusations and calls to investigate the WiV and the BSL-4 they are off the table and now we need to investigate the CCDC and a completely different lab
It's just a continuous cycle of searching for some new thing that hasn't been debunked yet, and you can bet that it will go full circle and it'll be back to calls for more investigation of the BSL-4 lab within a few days.
I don't see "section of the report" in my sentence at all.
I noted another salient fact: four GISAID sequences collected in Guangdong that fall in a putative progenitor node are from two different clusters of patients who traveled to Wuhan in late December of 2019 and developed symptoms before or on the day that they returned to Guangdong, where their viruses were ultimately sequenced (Chan et al. 2020; Kang et al. 2020b). Since these patients were clearly infected in Wuhan even though they were sequenced in Guangdong, I annotated them separately from both the other Wuhan and other China sequences.
Jesse D. Bloom's preprint is not "evidence of early cases originating in Guangdong".
You highlighted that patients were clearly infected in Wuhan.I noted another salient fact: four GISAID sequences collected in Guangdong that fall in a putative progenitor node are from two different clusters of patients who traveled to Wuhan in late December of 2019 and developed symptoms before or on the day that they returned to Guangdong, where their viruses were ultimately sequenced (Chan et al. 2020; Kang et al. 2020b). Since these patients were clearly infected in Wuhan even though they were sequenced in Guangdong, I annotated them separately from both the other Wuhan and other China sequences.
Evidence and characteristics of human-to-human transmission of sars-cov-2 is a February 17, 2020 preprint. Family cluster A looks like the same family cluster (5 cases, "stayed in Wuhan during December 29, 2019 to January 4, 2020"). Figure 1 ("Spatio-temporal distribution of cases in Guangdong Province, China, by February 10, 2020" ) starts on 1 January 2020. Figure 2 has the first Guangdong Province cluster on 16 January 2020 (a family cluster).From Jan 10, 2020, we enrolled a family of six patients who travelled to Wuhan from Shenzhen between Dec 29, 2019 and Jan 4, 2020.
The cave the WIV was heavily involved in studying bats from.At the beginning of the SARS epidemic, almost all early index patients had animal exposure before developing disease. After the causative agent of SARS was identified, SARS-CoV and/or anti-SARS-CoV antibodies were found in masked palm civets (Paguma larvata) and animal handlers in a market place12,16,39–42. However, later, wide-reaching investigations of farmed and wild-caught civets revealed that the SARS-CoV strains found in market civets were transmitted to them by other animals16,39. In 2005, two teams independently reported the discovery of novel coronaviruses related to human SARS-CoV, which were named SARS-CoV-related viruses or SARS-like coronaviruses, in horseshoe bats (genus Rhinolophus)15,43. ...
A 5-year longitudinal study revealed the coexistence of highly diverse SARSr-CoVs in bat populations in one cave of Yunnan province, China18,20,55.
it is highly likely that SARS-CoV newly emerged through recombination of bat SARSr-CoVs in this or other yet-to-be-identified bat caves. This hypothesis is consistent with previous data showing that a direct progenitor of SARS-CoV emerged before 2002 (refs42,57,58). Recombination analysis also strongly supported the hypothesis that the civet SARS-CoV strain SZ3 arose through recombination of two existing bat strains, WIV16 and Rf4092 (ref.20). Furthermore, WIV16, the closest relative to SARS-CoV found in bats, likely arose through recombination of two other prevalent bat SARSr-CoV strains20. ...
Because there were no SARS cases in Yunnan province during the SARS outbreak, we hypothesize that the direct progenitor of SARS-CoV was produced by recombination within bats and then transmitted to farmed civets or another mammal, which then transmitted the virus to civets by faecal–oral transmission. When the virus-infected civets were transported to Guangdong market, the virus spread in market civets and acquired further mutations before spillover to humans.
On the basis of SARS spread, the SARS 2002–2003 outbreak could be divided into three phases, with the early phase characterized by a limited number of localized cases, followed by a middle phase during which a superspreader event occurred in a hospital and finally the late phase of international spread62. The viral genomes from early-phase patients contain two genotypes of orf8, one with a complete orf8 (369 nucleotides) and the other containing an 82-nucleotide deletion. By contrast, viral genomes from late-phase patients and most of the genomes from middle-phase patients contain a split orf8 (orf8a and orf8b) owing to a 29-nucleotide deletion; two exceptions were found in middle-phase genomes, one containing an 82-nucleotide deletion in orf8 and the other with the whole orf8 deleted. The human isolates from 2004 and all civet SARS-CoV genomes have a complete orf8 except one civet strain with an 82-nucleotide deletion62. These data indicate that orf8 genes underwent adaptations during transmission from animals to humans during the SARS epidemic.
A post ignoring her latest error in many errors over the last week.Let's see, ..
Jesse D. Bloom has an impressive publishing history so the preprint should be correct and be published.bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.
And what does a just as credible news sources say?And once again, in reference to potential lab accidents, I believe I posted this recently: Senior Chinese scientist acquired SARS-CoV-2 in lab infection accident, virologist says
Followed by "Your former colleague was infected with sars2 in the lab?" question from Lishan Su and a "Yes, he was infected in the lab!" email from Shan-Lu Liu. That is an unsupported assertion that no credible news agency would print by itself.F om u Shan- u
To h h
Subje t Re Eme g ng M c bes & Infect ons - TEMI-20 0-0121 - changes qui ed o ou subm s ion
Date iday eb ua y 4 2020 6 13 2 M
I just finished reading Feng’s paper – indeed ery good.
Small e ror noted in he f rst paragraph “Know ng he origin of such a pa hogen is critical to de elop ng means to blocking further transm ssion and to de elop accines”. I saw this kind of error frequent for asian people but no big deal.
Feng Gao s my 师兄 in 北京的病毒所 we we e from the same lab where my former director has now been infec ed by SARS CoV 2! Ve y sad but he s doing OK!
Shan-Lu
Your many errors about science are relevant in a Science, Mathematics, Medicine, and Technology section. Preprints are not peer-reviewed science as everyone knows. I did look at the preprint."She even misses" ...
That is not how labs working with bat coronaviruses would do research. They do not house bats and hope for recombination events such as those that created SARS-1Origin and evolution of pathogenic coronaviruses
Where is the evidence of this sequence of adaptation events in SARS CoV2? Could it be there isn't any because this adaptation took place in a lab? Why yes, yes it could be that.
Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by severe acute respiratory syndrome coronavirus (SARS-CoV or SARS-CoV-1), the first identified strain of the SARS coronavirus species severe acute respiratory syndrome–related coronavirus (SARSr-CoV). The syndrome caused the 2002–2004 SARS outbreak. Around late 2017, Chinese scientists traced the virus through the intermediary of Asian palm civets to cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan.[3]